Insiders · Profile

Noonberg Sarah B.

Chief Medical Officer at Metagenomi Therapeutics · Director at Protagonist Therapeutics. Filing since 10 Feb 2021. CIK 0001706301

Company

Date

Role

Action

Amount

Of holding

6 Jun 2025

Chief Medical Officer

Sold at will

5,239

$9.17K

4.6%

11 Feb 2021

Director

Sold, plan not stated

3,700

$92.83K

100%

10 Feb 2021

Director

Sold, plan not stated

4,700

$119.72K

100%

3 decisions on file.